MedPath

海南皇隆制药股份有限公司

Ownership
-
Established
1995-08-24
Employees
-
Market Cap
-
Website
http://www.hnhuanglong.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

77

NMPA:77

Drug Approvals

Acetylcysteine Solution for Inhalation

Product Name
吸入用乙酰半胱氨酸溶液
Approval Number
国药准字H20254128
Approval Date
May 13, 2025
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20249596
Approval Date
Dec 1, 2024
NMPA

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20249595
Approval Date
Dec 1, 2024
NMPA

Trimetazidine Dihydrochloride

Product Name
盐酸曲美他嗪
Approval Number
国药准字H20083220
Approval Date
Jul 4, 2024
NMPA

Azithromycin Soft Capsules

Product Name
奇谷美
Approval Number
国药准字H20061229
Approval Date
Jul 4, 2024
NMPA

Amrinone

Product Name
氨力农
Approval Number
国药准字H20083141
Approval Date
Jul 4, 2024
NMPA

Vaginal Chloramphenicol Soft Capsules

Product Name
氯霉素阴道软胶囊
Approval Number
国药准字H20057036
Approval Date
Jun 26, 2024
NMPA

Venlafaxine Hydrochloride

Product Name
盐酸文拉法辛
Approval Number
国药准字H20065994
Approval Date
Jun 25, 2024
NMPA

Dirithromycin

Product Name
地红霉素
Approval Number
国药准字H20060737
Approval Date
Jun 25, 2024
NMPA

Enoxacin Gluconate

Product Name
葡萄糖酸依诺沙星
Approval Number
国药准字H20056002
Approval Date
Jun 21, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.